SCI Stock Recent News

Key Points Green funerals are poised to grow quickly in the coming decades. A number of death care firms are ready for the secular trend. The shift to eco-friendly funerals won’t happen overnight. With a small market and a lack of pure-plays to bet on the trend, investment options are rather limited. Are you ahead, or behind on retirement? SmartAsset’s free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don’t waste another minute; get started by clicking here.(Sponsor) The concept of green funerals (eco-friendly funerals) has seen a surge in interest in recent years, especially among younger generations, many of whom have shown a preference for traditional burials over emission-heavy cremations. And while funerals are a morbid topic that many of today’s young people seek not to discuss, I do think that the death care industry’s green shift will be unavoi

Service Corporation International operates in a stable, fragmented industry with strong margins, predictable revenue, and a $16B backlog driven by preneed contracts and demographic trends. The company has a 20-year track record of consistent growth in revenue, cash flow, and shareholder returns through dividends and aggressive share buybacks. Even using conservative assumptions, SCI's valuation shows an IRR above 8%, with room for upside if margins or terminal growth rates exceed expectations.

Service Corporation International remains a 'buy' due to its industry leadership, stable growth, and strong long-term demographic tailwinds. The company's asset clustering strategy and fragmented market offer significant acquisition and cost-saving opportunities for continued expansion. Transition to insurance-funded pre-need contracts should improve margins and sales growth, with management guiding for stronger performance in 2026.

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #HNSCC--FDA's Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI's Multikine.

Even as Warren Buffett prepares to officially retire as CEO of Berkshire Hathaway Inc. NYSE: BRK.B, investors are likely to continue to honor his legacy by emulating his investing strategies. One of the hallmarks of Buffett's approach is identifying exceptional stocks and maintaining positions in them for a long time—even decades in many cases.

Service Corp. (SCI) reported earnings 30 days ago. What's next for the stock?

VIENNA, Va.--(BUSINESS WIRE)---- $CVM--CEL-SCI announces closing of public offering.

VIENNA, Va.--(BUSINESS WIRE)---- $CVM--CEL-SCI announces pricing of public offering.

VIENNA, Va.--(BUSINESS WIRE)---- $CVM--CEL-SCI announces proposed public offering.

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI'S Multikine investigational cancer medicine potentially available for commercialization by summer 2025 in Saudi Arabia.